proglumide has been researched along with Cancer of Liver in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Chen, W; Duka, T; Gay, MD; Golnazar, S; He, AR; Kallakury, B; Shivapurkar, N; Smith, JP; Vasudevan, S | 1 |
| Cao, H; Gay, MD; Kroemer, A; Liu, FH; Malchiodi, ZX; Safronenka, A; Shivapurkar, N; Smith, JP; Tucker, RD | 1 |
| Cao, H; Ciofoaia, V; Gay, MD; Huber, M; Kallakury, B; Kroemer, AHK; Kruger, AJ; Nadella, S; Safronenka, A; Shivapurkar, N; Smith, JP; Tucker, RD | 1 |
| Anand, A | 1 |
| Hiratsuka, M; Imaoka, S; Ishikawa, O; Kabuto, T; Kameyama, M; Nakamori, S; Nakano, H; Ohigashi, H; Sasaki, Y; Yasuda, T | 1 |
| Furukawa, H; Hiratsuka, M; Imaoka, S; Ishikawa, O; Kabuto, T; Kameyama, M; Murata, K; Nakano, H; Ohigashi, H; Sasaki, Y; Tsugawa, T; Yasuda, T | 1 |
| Funakoshi, A; Kono, A; Shimazoe, T | 1 |
| Funakoshi, A; Kono, A | 1 |
| Harrison, JD; Jones, JA; Morris, DL | 1 |
| Ballantyne, KC; Charnley, RM; Jones, J; Morris, DL | 1 |
3 trial(s) available for proglumide and Cancer of Liver
| Article | Year |
|---|---|
[Adjuvant chemo-endocrine chemotherapy with gastrin antagonist after resection of liver metastasis in colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Doxorubicin; Female; Floxuridine; Gastrins; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Proglumide | 1994 |
The effect of the gastrin receptor antagonist proglumide on survival in gastric carcinoma.
Topics: Aged; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Proglumide; Receptors, Cholecystokinin; Stomach Neoplasms; Survival Rate | 1990 |
A pilot randomized control trial of proglumide (a gastrin receptor antagonist) in advanced colorectal cancer.
Topics: Adenocarcinoma; Carcinoembryonic Antigen; Colorectal Neoplasms; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Pilot Projects; Proglumide; Survival Rate | 1990 |
7 other study(ies) available for proglumide and Cancer of Liver
| Article | Year |
|---|---|
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cholecystokinin; Fibrosis; Immune Checkpoint Inhibitors; Liver Neoplasms; Mice; Proglumide; Receptors, Cholecystokinin | 2023 |
Targeting the Cholecystokinin Receptor: A Novel Approach for Treatment and Prevention of Hepatocellular Cancer.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemokines, CC; Cholecystokinin; Diet, High-Fat; Disease Models, Animal; Female; Gene Knockout Techniques; Hepatic Stellate Cells; Humans; Liver; Liver Neoplasms; Male; Mice; Non-alcoholic Fatty Liver Disease; Proglumide; Receptor, Cholecystokinin B | 2021 |
A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Choline Deficiency; Disease Models, Animal; Epigenesis, Genetic; Ethionine; Female; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Liver; Liver Neoplasms; Mice, Inbred C57BL; MicroRNAs; Non-alcoholic Fatty Liver Disease; Proglumide; Receptor, Cholecystokinin B; Signal Transduction | 2020 |
Colorectal carcinoma: prognostic significance of gastrin.
Topics: Colorectal Neoplasms; Gastrins; Humans; Indoles; Liver Neoplasms; Predictive Value of Tests; Proglumide; Prognosis | 1995 |
[Adjuvant intra-arterial chemotherapy with gastrin receptor antagonist after hepatic resection in colorectal cancer metastasis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Doxorubicin; Drug Administration Schedule; Floxuridine; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Mitomycin; Proglumide; Receptors, Cholecystokinin | 1998 |
[Effects of UFT and loxiglumide (CR1505) on liver metastasis of human pancreatic cancer cell line, KP-1 N in nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cholecystokinin; Humans; Liver Neoplasms; Mice; Mice, Nude; Pancreatic Neoplasms; Proglumide; Tegafur; Tumor Cells, Cultured; Uracil | 1992 |
Growth inhibition of human pancreatic cancer cells by cholecystokinin receptor antagonist in tissue culture and in nude mice.
Topics: Adenocarcinoma; Animals; Ceruletide; Cholecystokinin; Humans; In Vitro Techniques; Liver Neoplasms; Mice; Mice, Nude; Pancreatic Neoplasms; Proglumide; Tumor Cells, Cultured | 1992 |